Cargando…
Risk reduction with clopidogrel in the management of peripheral arterial disease
Peripheral arterial disease (PAD) is a condition typified by decreased arterial blood flow in the non-coronary branches of the aorta as a result of chronic atherosclerosis. Despite the higher prevalence of PAD compared with other cardiovascular entities such as myocardial infarction and stroke, far...
Autores principales: | R Nayak, Keshav, J Cavendish, Jeffrey |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2293969/ https://www.ncbi.nlm.nih.gov/pubmed/17703636 |
Ejemplares similares
-
Modern role for clopidogrel in management of atrial fibrillation and stroke reduction
por: Maegdefessel, Lars, et al.
Publicado: (2010) -
3480 Association of Clopidogrel Resistance Determinants and MACE Ocurrence in Peripheral Arterial Disease
por: Nunez Medina, Hector Jose
Publicado: (2019) -
Pharmacoeconomic Analysis of Clopidogrel in
Secondary Prevention of Coronary Artery Disease
por: Cheng, Judy W.
Publicado: (2007) -
Clopidogrel: A Pharmacogenomic Perspective on its Use in Coronary Artery Disease
por: Terpening, Chris
Publicado: (2010) -
Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary intervention
por: Dasgupta, Arijit, et al.
Publicado: (2009)